Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Stock-Based Compensation | ||
| Stock-based compensation expense | $ 931 | $ 1,088 |
| Divestiture of Orthobiologics | Discontinued Operations, Held-for-sale | ||
| Stock-Based Compensation | ||
| Stock-based compensation expense included within discontinued Operations | 100 | |
| Sales and marketing | ||
| Stock-Based Compensation | ||
| Stock-based compensation expense | 43 | 66 |
| General and administrative | ||
| Stock-Based Compensation | ||
| Stock-based compensation expense | 715 | 859 |
| Research and development | ||
| Stock-Based Compensation | ||
| Stock-based compensation expense | $ 173 | 143 |
| Cost of goods sold | ||
| Stock-Based Compensation | ||
| Stock-based compensation expense | $ 20 | |